Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2002-10-29
2003-07-08
Ramsuer, Robert W. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06589974
ABSTRACT:
The invention relates to novel pyrazolyl benzyl ethers, to a plurality of processes for their preparation and to their use for controlling harmful organisms.
Certain compounds having a similar substitution pattern, and their fungicidal action, are already known (WO 98/55461, WO 97/07103, WO 96/10556, WO 96/06072, WO 99/33812, DE-A 4424788). However, the activity of these prior-art compounds is, in particular at low application rates and concentrations, not entirely satisfactory in all areas of use.
This invention now provides the novel pyrazolyl benzyl ethers of the general formula (I)
in which
A represents oxygen or —NH—,
R represents in each case optionally substituted alkyl, cycloalkyl or aryl,
L
1
, L
2
, L
3
and L
4
are identical or different and independently of one another each represents hydrogen, halogen, cyano, nitro, in each case optionally halogen-substituted alkyl, alkoxy, alkylthio, alkylsulphinyl or alkylsulphonyl.
In the definitions, the saturated or unsaturated hydrocarbon chains, such as alkyl, alkanediyl, alkenyl or alkinyl, are in each case straight-chain or branched, including in combination with heteroatoms, such as, for example, in alkoxy, alkylthio or alkylamino.
Unless indicated otherwise, preference is given to hydrocarbon chains having 1 to 6 carbon atoms.
Aryl represents aromatic mono- or polycyclic hydrocarbon rings, such as, for example, phenyl, naphthyl, anthranyl, phenanthryl, preferably phenyl or naphthyl, in particular phenyl.
Heterocyclyl represents saturated or unsaturated and also aromatic cyclic compounds in which at least one ring member is a heteroatom, i.e. an atom different from carbon. If the ring contains a plurality of heteroatoms, these can be identical or different. If the ring contains a plurality of oxygen atoms, these are not adjacent. Preferred heteroatoms are oxygen, nitrogen and sulphur. If appropriate, the cyclic compounds form, together with further carbocyclic or heterocyclic fused-on or bridged rings, a polycyclic ring system. Preference is given to mono- or bicyclic ring systems, in particular to mono- or bicyclic aromatic ring systems. A polycyclic ring system can be attached via the heterocyclic ring or via a fused-on carbocyclic ring.
Cycloalkyl represents saturated carbocyclic compounds which, if appropriate, form a polycyclic ring system together with further carbocyclic fused-on or bridged rings.
Furthermore, it has been found that the novel pyrazolyl benzyl ethers of the general formula (I) are obtained when
a) benzyl halides of the formula (II)
in which
A, L
1
, L
2
, L
3
and L
4
are as defined above and
X represents halogen,
are reacted with a substituted pyrazolone of the general formula (III),
in which
R is as defined above, if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor, or when
b) pyrazolyl benzyl ethers of the formula (I) where A is oxygen are reacted with methylamine, if appropriate in the presence of a diluent.
Finally, it has been found that the novel pyrazolyl benzyl ethers of the general formula (I) are highly active against harmful organisms and exhibit in particular very strong fungicidal and insecticidal action.
The active-compounds according to the invention may also, at certain concentrations and application rates, exhibit activity against plant pests.
If appropriate, the compounds according to the invention can be present as mixtures of different possible isomeric forms, in particular of stereoisomers, such as, for example, E and Z. What is claimed are both the E and the Z isomers, and any mixtures of these isomers.
The invention preferably provides compounds of the formula (I) in which
A represents oxygen or —NH—,
R represents alkyl having 1 to 8 carbon atoms,
represents cycloalkyl having 3 to 7 carbon atoms which is optionally mono- or disubstituted by halogen, alkyl or hydroxyl;
or represents phenyl or naphthyl, each of which is optionally mono- to tetrasubstitued by identical of different substituents, where the possible substituents are preferably selected from the list below:
halogen, cyano, nitro, amino, hydroxyl, formyl, carboxyl, carbamoyl, thiocarbamoyl;
in each case straight-chain or branched alkyl, hydroxyalkyl, oxoalkyl, alkoxy, alkoxyalkyl, alkylthioalkyl, dialkoxyalkyl, alkylthio, alkylsulphinyl or alkylsulphonyl having in each case 1 to 8 carbon atoms;
in each case straight-chain or branched alkenyl or alkenyloxy having in each case 2 to 6 carbon atoms;
in each case straight-chain or branched halogenoalkyl, halogenoalkoxy, halogenoalkylthio, halogenoalkylsulphinyl or halogenoalkylsulphonyl having in each case 1 to 6 carbon atoms and 1 to 13 identical or different halogen atoms;
in each case straight-chain or branched halogenoalkenyl or halogenoalkenyloxy having in each case 2 to 6 carbon atoms and 1 to 11 identical or different halogen atoms;
in each case straight-chain or branched alkylamino, dialkylamino, alkylcarbonyl, alkylcarbonyloxy, alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylalkylaminocarbonyl, dialkylaminocarbonyloxy, alkenylcarbonyl or alkinylcarbonyl, having 1 to 6 carbon atoms in the respective hydrocarbon chains;
cycloalkyl or cycloalkyloxy having in each case 3 to 6 carbon atoms;
in each case doubly attached alkylene having 3 or 4 carbon atoms, oxyalkylene having 2 or 3 carbon atoms or dioxyalkylene having 1 or 2 carbon atoms, each of which radicals is optionally mono- to tetrasubstituted by identical or different substituents from the group consisting of fluorine, chlorine, oxo, methyl, trifluoromethyl and ethyl;
or a group
in which
A
1
represents hydrogen, hydroxyl or alkyl having 1 to 4 carbon atoms or cycloalkyl having 3 to 6 carbon atoms and
A
2
represents hydroxyl, amino, methylamino, phenyl, benzyl or represents in each case optionally cyano-, hydroxyl-, alkoxy-, alkylthio-, alkylamino-, dialkylamino- or phenyl-substituted alkyl or alkoxy having 1 to 4 carbon atoms, or represents alkenyloxy or alkinyloxy having in each case 2 to 4 carbon atoms,
and phenyl, phenoxy, phenylthio, benzoyl, benzoylethenyl, cinnamoyl, heterocyclyl or phenylalkyl, phenylalkyloxy, phenylalkylthio, or heterocyclylalkyl having in each case 1 to 3 carbon atoms in the respective alkyl moities, each of which radicals is optionally mono- to trisubstituted in the ring moiety by halogen and/or straight-chain or branched alkyl or alkoxy having 1 to 4 carbon atoms,
L
1
, L
2
, L
3
and L
4
are identical or different and independently of one another each represents hydrogen, halogen, cyano, nitro, or represents alkyl, alkoxy, alkylthio, alkylsulphinyl or alkylsulphonyl having in each case 1 to 6 carbon atoms, each of which radicals is optionally substituted by 1 to 5 halogen atoms.
The invention relates in particular to compounds of the formula (I) in which
A represents oxygen or —NH—,
R represents methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, pentyl or hexyl, or represents cyclopentyl or cyclohexyl, each of which is optionally mono- or disubstituted by fluorine, chlorine, methyl, ethyl or hydroxyl;
or represents phenyl or naphthyl, each of which is optionally mono- to tetrasubstituted by identical or different substituents, where the possible substituents are preferably selected from the list below:
fluorine, chlorine, bromine, iodine, cyano, nitro, amino, hydroxyl, formyl, carboxyl, carbamoyl, thiocarbamoyl,
methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, 1-, 2-, 3-, neo-pentyl, 1-, 2-, 3-, 4-(2-methylbutyl), 1-, 2-, 3-hexyl, 1-, 2-, 3-, 4-, 5-(2-methylpentyl), 1-, 2-, 3-(3-methylpentyl), 2-ethylbutyl, 1-, 3-, 4-(2,2-dimethylbutyl), 1-, 2-(2,3-dimethylbutyl), hydroxymethyl, hydroxyethyl, 3-oxobutyl, methoxymethyl, dimethoxymethyl,
methoxy, ethoxy, n- or i-propoxy, methoxymethyl, ethoxymethyl, methylthio, ethylthio, n- or i-propylthio, methylsulphinyl, ethylsulphinyl, methylsulphonyl or ethylsulphonyl, methylthiomethyl, ethylthiomethyl,
vinyl, allyl, 2-methylallyl, propen-1-yl, crotonyl, propargyl, vinyloxy, allyloxy, 2-methylallyloxy, propen-1-yloxy, crotonyloxy, propargyloxy;
tri
Erdelen Christoph
Gayer Herbert
Gerdes Peter
Hänssler Gerd
Heinemann Ulrich
Bayer Aktiengesellschaft
Harmuth Raymond J.
Henderson Richard E. L.
Ramsuer Robert W.
LandOfFree
Pyrazolyl benzyl ether derivatives containing a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolyl benzyl ether derivatives containing a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolyl benzyl ether derivatives containing a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3092681